0000905718-19-000900.txt : 20191112 0000905718-19-000900.hdr.sgml : 20191112 20191112070653 ACCESSION NUMBER: 0000905718-19-000900 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191112 DATE AS OF CHANGE: 20191112 EFFECTIVENESS DATE: 20191112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CytoDyn Inc. CENTRAL INDEX KEY: 0001175680 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 753056237 STATE OF INCORPORATION: DE FISCAL YEAR END: 0531 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-336290 FILM NUMBER: 191206022 BUSINESS ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 BUSINESS PHONE: 360-980-8524 MAIL ADDRESS: STREET 1: 1111 MAIN STREET, SUITE 660 CITY: VANCOUVER STATE: WA ZIP: 98660 FORMER COMPANY: FORMER CONFORMED NAME: CYTODYN INC DATE OF NAME CHANGE: 20031114 FORMER COMPANY: FORMER CONFORMED NAME: REXRAY CORP DATE OF NAME CHANGE: 20020617 D/A 1 primary_doc.xml X0708 D/A LIVE 0001175680 CytoDyn Inc. 1111 MAIN STREET, SUITE 660 VANCOUVER WA WASHINGTON 98660 360-980-8524 DELAWARE RexRay Corporation CYTODYN INC REXRAY CORP Corporation true Nader Z. Pourhassan c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Director Michael D. Mulholland c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Executive Officer Jordan G. Naydenov c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Michael A. Klump c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Scott A. Kelly c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director David F. Welch c/o CytoDyn Inc. 1111 Main Street, Suite 660 Vancouver WA WASHINGTON 98660 Director Biotechnology Decline to Disclose 06b true 0000905718-19-000315 2019-03-20 false true true true true Convertible Preferred Stock with Warrants false 0 Paulson Investment Company, LLC 5670 None None 2141 W. NORTH AVE. 2ND FLOOR CHICAGO IL ILLINOIS 60647 All States false 20000000 7788000 12212000 false 61 1800000 true 0 Assumes maximum fees earned. 0 true Some of the proceeds may be used for general working capital purposes which may include the payment of salaries and other fees to those listed in Item 3. false CytoDyn Inc. /s/ Michael D. Mulholland Michael D. Mulholland Chief Financial Officer 2019-11-12